New anti-clotting drugs linked to lower risk of serious bleeding
New drugs known as direct oral anticoagulants (DOACs) used to treat serious blood clots are associated with reduced risks of major bleeding compared with the older anti-clotting drug, warfarin, finds a study in The BMJ today.
Jul 4, 2018
0
8